Medigus Ltd
Change company Symbol lookup
Select an option...
MDGS Medigus Ltd
WLDS Wearable Devices Ltd
UP Wheels Up Experience Inc
BRTX BioRestorative Therapies Inc
FRZA Forza X1 Inc
ILMN Illumina Inc
NR Newpark Resources Inc
CGC Canopy Growth Corp
NAOV Nanovibronix Inc
ETON Eton Pharmaceuticals Inc

Health Care : Health Care Equipment & Supplies |
Based in Israel
Company profile

Medigus is a Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras underr micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD)

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
Day's Change
0.62 (11.44%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

US Nuclear Combats PFAS Contamination With Novel, On-the-Spot Detector

8:30 am ET March 20, 2023 (Globe Newswire) Print
US Nuclear Combats PFAS Contamination With Novel, On-the-Spot DetectorGlobeNewswireMarch 20, 2023

LOS ANGELES, CA, March 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- On Tuesday, March 14, 2023, the US Environmental Protection Agency (EPA) proposed a first-ever national standard establishing legally enforceable limits for six toxic PFAS forever chemicals. This was welcome news for US Nuclear Corp. (OTC-QB: UCLE) who recently developed and started selling the world's first real-time PFAS monitor that can measure PFAS contamination in under a minute. Until now, there were only a few states that enforced PFAS regulations, and none as strict as what the EPA is now proposing. Public concern has grown substantially in recent years as new testing revealed the extent and danger of PFAS contamination to all Americans. If the proposal is finalized, businesses and drinking water providers across the country will need to start monitoring and regulating PFAS levels, and should certainly benefit from US Nuclear's real-time monitor that can measure PFAS on the spot.

Due to its long unregulated use, PFAS contamination has become extremely widespread and can be found in our water (including drinking water), air, soil, consumer products, and has even been found in our food such as fish, shellfish, and meat. Scientists have estimated that the majority of Americans (over 200 million people) have tap water that is contaminated by PFAS chemicals. PFAS are known as 'forever chemicals' because they don't degrade, and can cause serious health issues such as cancer, low birthweight and defects, liver and kidney damage, heart attacks, and more. Fortunately, the EPA said that the proposed regulation could prevent thousands of deaths and reduce tens of thousands of PFAS-related illnesses.

The EPA has asked providers to test for PFAS, notify the public if PFAS contamination is found, and take steps to remove the chemicals if they are above the proposed limits. The proposal regulates two PFAS compounds as 'individual contaminants' with a maximum limit of 4 parts per trillion, while four other PFAS compounds are deemed a 'mixture' limiting the combined levels of those chemicals in water. Water utility providers that don't comply with the regulations could face steep fines or loss of federal grants.

US Nuclear's novel PFAS monitor utilizes a proprietary Surface Acoustic Wave (SAW) detector and ultra high-speed chromatography to accurately and rapidly detect PFAS contamination in water, other liquids, and gases through headspace analysis. These instruments are available in both portable (Model PFAS-TA-F) and stationary laboratory versions (Model PFAS-TA-L). Utilizing a trap and helium carrier gas, the PFAS-TA injects samples (~0.5ml/sec) into a heated column for separation, and the materials exiting the column are deposited on the SAW detector which results in a change to the oscillation frequency which is proportional to the molecular mass. Automatically identifies PFAS, hydrocarbons C4 to C25, and other compounds with a sensitivity as low as parts-per-trillion in 5-60 seconds, with an expandable library of 700+ chemical signatures. US Nuclear's PFAS monitors provide researchers, businesses, and utility companies with a very unique and useful tool that stands out from other far costlier, and time-consuming methods.

Safe Harbor Act

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at, or the company's website at


US Nuclear Corp. (OTC-QB: UCLE)

Robert I. Goldstein, President, CEO, and Chairman

Richard Landry, Chief Financial Officer

(818) 883 7043


Primary Logo

comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.